Researchers at the University of Pittsburgh and Carnegie Mellon University collaborated to create a customized app based on ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that ...

A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of ...

In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of some people who later went on to develop ...

"Mono," caused by Epstein-Barr virus, raises the risk of multiple sclerosis, but it's unclear why. A study pinpoints a genetic variant that might help explain.